Concepedia

Ko Takigami

KT

10

Publications

995

Citations

10

H-Index

1998

Active since

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Massachusetts Institute of Technology

Massachusetts General Hospital

Asahikawa Medical College Hospital

Ko Takigami is an author at Beth Israel Deaconess Medical Center specializing in medicine, xenotransplantation, and cardiac xenotransplantation.

Top concepts

Publications per year

1998–2000

10

Publications

10

Expression of heme oxygenase-1 can determine cardiac xenograft survival

Miguel P. Soares, Y. Lin, Josef Anrather et al. · Nature Medicine · 1998 · 614 citations

, , +6

Complement-Fixing Elicited Antibodies Are a Major Component in the Pathogenesis of Xenograft Rejection

T Miyatake, Koichiro Sato, Ko Takigami et al. · The Journal of Immunology · 1998 · 75 citations · Full text

, , +20

Accommodated Xenografts Survive in the Presence of Anti-Donor Antibodies and Complement That Precipitate Rejection of Naive Xenografts

Yuan Lin, Miguel P. Soares, Koichiro Sato et al. · The Journal of Immunology · 1999 · 69 citations · Full text

, , +19

RECOMBINANT ADENOVIRAL MEDIATED CD39 GENE TRANSFER PROLONGS CARDIAC XENOGRAFT SURVIVAL1

Masato Imai, Ko Takigami, Olaf Guckelberger et al. · Transplantation · 2000 · 64 citations

Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.

Masato Imai, Ko Takigami, Olaf Guckelberger et al. · PubMed · 1999 · 48 citations · Full text

Rows per page

1–5 of 10